Abstract:Key PointsBiopharmaceutical drugs such as antibodies, peptides and recombinant proteins have high specificity and potency compared to small molecules. These features arise from their macromolecular composition, which provides the structural complexity that is often required for specificity.However, this structural complexity means that biopharmaceutical drugs are large and susceptible to degradation, which makes it challenging to formulate and deliver them. These drugs also have reduced permeation across biological barriers, which complicates their delivery to specific sites or intracellular targets.In this Review we highlight recent advances in formulation and delivery strategies that have facilitated the transformation of product portfolios and development pipelines by this class of compounds. These advances include the use of microsphere-based sustained-release technologies, protein modification methods that make use of polyethylene glycol and other polymers, as well as genetic manipulation of biopharmaceutical drugs such as Fc- and albumin-fusions.We also highlight current and emerging delivery routes that provide alternatives to injection, including transdermal, oral and pulmonary delivery.Current areas of formulation and delivery research show promise for the application of biopharmaceutical drugs to tumour immunotherapy using nanoparticle technology, tissue engineering and enhanced approaches to cell-based therapy.These delivery methods could be used for the targeted delivery of proteins to the brain, which could have implications in the treatment of a wide range of central nervous system disorders. These technologies could potentially increase the effectiveness of conventional approaches that have not yet translated to the clinic, although they have had promising preclinical results.Intracellular delivery of proteins and peptides is a new frontier in delivery research, which could dramatically augment the breadth of targets amenable to biopharmaceutical drug therapy.

Successful treatment of large venous malformation with dual wavelength 595 and 1064 nm system

Strategies to Obtain Encapsulation and Controlled Release of Small Hydrophilic Molecules

Strategies for Improving Peptide Stability and Delivery

Formulation Aspects of Protein Stability and Complete Release in Poly(Lactic-co-glycolic acid)Microspheres

Microhabitat segregation in two desert rodent species: the relation of prey availability to diet

Challenges of peptide and protein drug delivery by oral route: Current strategies to improve the bioavailability

Therapeutic Peptides and Proteins: Stabilization Challenges and Biomedical Applications by Means of Nanodelivery Systems

Overcoming the challenges in administering biopharmaceuticals: formulation and delivery strategies

Instability Challenges and Stabilization Strategies of Pharmaceutical Proteins

Designing Formulation Strategies for Enhanced Stability of Therapeutic Peptides in Aqueous Solutions: A Review

Polymeric-based particulate systems for delivery of therapeutic proteins.

The industrial design, translation, and development strategies for long-acting peptide delivery

Metabolism of Peptide Drugs and Strategies to Improve their Metabolic Stability

Polymer-Based Sustained-Release Dosage Forms for Protein Drugs, Challenges, and Recent Advances

Maillard conjugate-based delivery systems for the encapsulation, protection, and controlled release of nutraceuticals and food bioactive ingredients: A review

Molecular Mechanisms for Stabilizing Biologics in the Solid State

Oral peptide and protein delivery: intestinal obstacles and commercial prospects

PLGA-based implants for sustained delivery of peptides/proteins: Current status, challenge and perspectives

High-performance liquid chromatographic determination of ferulic acid in wheat milling fractions as a measure of bran contamination.

Oral delivery of protein and peptide drugs: from non-specific formulation approaches to intestinal cell targeting strategies

Combined leukocyte and erythrocyte aggregation in patients with acute myocardial infarction.